News Releases

  LONDON, U.K. AND DALLAS, TX, U.S. – Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, notes that Rosecliff Acquisition Corp I (“Rosecliff”, Nasdaq: RCLF) has filed on August

  LONDON, U.K. AND DALLAS, TX, U.S . -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, notes that Rosecliff Acquisition Corp I (“Rosecliff”, Nasdaq: RCLF) has filed on 8

  As stated in the announcement on April 11, 2023, detailing the planned business combination (the “Transaction”) with Rosecliff Acquisition Corp I (“Rosecliff”), the Board of Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster

LONDON, U.K. AND DALLAS, TX, U.S.  -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, has issued an updated corporate presentation (“Corporate Presentation”) to be consistent

Unaudited results for the Quarter Ended 31 March 2023 Filing of Updated Form S-4 by Rosecliff Acquisition Corp I LONDON, U.K. AND DALLAS, TX, U.S . -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment

LONDON, U.K. AND DALLAS, TX, U.S. –  Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, notes that Spectral MD is making available a corporate presentation (“Corporate

20 June 2023 ISO 13485 Certification Recommended and Anticipated in Q3 2023 LONDON, U.K. AND DALLAS, TX, U.S  -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announces it

Podium Presentation Highlights Opportunity to Improve Burn Wound Healing Assessment LONDON & DALLAS–( BUSINESS WIRE )– Spectral MD Holdings, Ltd. (AIM: SMD) , an artificial intelligence (AI) company focused on the development of faster and more accurate medical diagnostics for treatment decisions

Filing of Form S-4 and Mailing of Definitive Proxy Statement by Rosecliff Acquisition Corp. I LONDON, U.K. AND DALLAS, TX, U.S. -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound

LONDON, U.K. AND DALLAS, TX, U.S. -Spectral MD Holdings, Ltd. (AIM: SMD), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, notes the Form 8-K filing (the “Form 8-K”) by Rosecliff Acquisition Corp.